Psychiatr. pro Praxi, 2005; 2: 66-70

ANTIDEPRESSANTS IN THE TREATMENT OF MALE SEXUAL DYSFUNCTION

prof. MUDr. Alexandra Žourková CSc
Psychiatrická klinika LF MU a FN Brno

The author describes studies of therapeutic efficaccy of antidepressants in the treatment of male sexual dysfunction. Antidepressants stimulating sexual activity (moclobemide, bupropion, trazodone) demonstrate good results in the therapy of decreased libido and erectile dysfunction, serotonergic antidepressants are used in the treatment of premature ejaculation.

Keywords: Key words: sexual dysfunction, therapy, antidepressants.

Published: February 1, 2006  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Žourková A. ANTIDEPRESSANTS IN THE TREATMENT OF MALE SEXUAL DYSFUNCTION. Psychiatr. praxi. 2005;9(2):66-70.
Share...
Download citation
  • BibTeX (.bib)
  • Bookends (.ris)
  • EasyBib (.ris)
  • EndNote (.enw)
  • EndNote 8 (.xml)
  • ISI WoS (.isi)
  • Medlars (.medlars)
  • Mendeley (.ris)
  • MODS (.xml)
  • Papers (.ris)
  • RefWorks (.txt)
  • RefManager (.ris)
  • RIS (.ris)
  • MS Word (.xml)
  • Zotero (.ris)
    • Open full article

    References

    1. Clayton AH, McGarvey EL, Clavet GJ, Piazza L. Comparison of sexual functioning in clinical and nonclinical populations using the Changes in sexual functioning questionnaire (CSFQ), Psychophamacology Bulletin, 1997; 33: 731-745.
    2. Fink HA, MacDonald R, Rutks IR, Wilt TJ. Trazodone for erectile dysfunction: a systematic review and meta-analysis, BJU Int., 2003; 92: 441-446. Go to original source... Go to PubMed...
    3. Gessa GL, Tagliamonte A. Role of brain serotonin and dopamine in male sexual behavior.In: Sarden M., Gessa G.L. (Eds.): Sexual behavior, pharmacology and biochemistry.New York, Raven Press, 1975; 117-128. Go to original source...
    4. Gregorian RS, Golden KA, Bahce A, Goodman C, Kwong WJ, Khan ZM. Antidepressant-induced sexual dysfunction, The Annals of Pharmacotherapy, 2002; 36: 1577-1589. Go to original source... Go to PubMed...
    5. Kennedy SH, Ralevski E, Davis C, Nietzert C. The effects of moclobemide on sexual desire and function in healthy volunteers, Eur. Neuropsychopharmacol., 1996; 6: 177-181. Go to original source... Go to PubMed...
    6. Kennedy SH, Eisfeld BS, Dickens SE, Bacchiochi JR, Bagby RM. Antidepressant-induced sexual dysfunction during treatment with moclobemide, paroxetine, sertraline and venlafaxine, J.Clin. Psychiatry, 2000; 61: 276-281. Go to original source... Go to PubMed...
    7. Kolomazník M, Červinka L, Kutílek Š, Pohanka M, Skibová J, Tauš L, Vilč M, Zapletálek M, Zbytovský J, Zemková P. Fluoxetin v léčbě ejaculatio praecox, Psychiatrie, 2002; 6: 6-9.
    8. Kolomazník M. Léčba předčasné ejakulace intermitentně podávaným sertralinem, Psychiatrie, 2004; 8: 100-103.
    9. Kolomazník M, Kolomazník J, Richterová M. Moklobemid v léčbě erektilních dysfunkcí, Čes. a slov. Psychiat., 2004; 100: 191-196.
    10. Lingjaerde O, Ahlfors VG, Dencker SJ, Elgen K. The UKU side effects rating scale for psychotropic drugs and a cross sectional study of side effects in antipsychotic patients. Acta Psychiatr. Scand. Suppl. 1987: 1-100. Go to original source... Go to PubMed...
    11. Maršálek M. Sexuální dysfunkce při léčbě antidepresivy, Psychiatr pro praxi, 2003; 4: 94-100.
    12. Mathew RJ, Weinman JL. Sexual dysfunction in depression, Arch.Sex.Behav., 1982; 11: 323-325. Go to original source... Go to PubMed...
    13. McGahuey CA, Delgado PL, Gelenberg AJ. Assessment of sexual dysfunction using the Arizona sexual experiences scale (ASEX) and implications for the treatment of depression. Psychiatric annals 1999; 29: 39-45. Go to original source...
    14. Mellis MR, Argiolas A. Dopamine and sexual behavior, Neurosc. Biobehav. Rev., 1995; 19: 19-38. Go to original source... Go to PubMed...
    15. Meston CM, Gorzalka BB. Psychoactive drugs and human sexual behaviour: the role of serotonergic activity, J.Psychoactive Drugs 1992; 24: 1-40. Go to original source... Go to PubMed...
    16. Meston CM, Frolich PF. The Neurobiology of Sexual Function, Arch. Gen. Psychiatry, 2000; 57: 1012-1030. Go to original source... Go to PubMed...
    17. Pollack M-H, Reiter S, Hammerness P. Genitourinary and sexual adverse effects of psychotropic medication, Int. J. Psychiatry in Medicine 1992; 22: 305-327. Go to original source... Go to PubMed...
    18. Riley AJ, Riley EJ. Cholinergic and adrenergic control of human sexual responses, In: Wheatley D. (Eds.) Psychopharmacology nad sexual disorders, New York, Oxford University Press Inc., 1983; 129-137.
    19. Riley AJ. Alpha adrenoreceptors and human sexual function In: Bancroft J., ed. The Pharmacology of Sexual Function and Dysfunction.Amsterdam: Elsevier Science BV 1995; 307-322.
    20. Segraves RT, Balon R. Sexual pharmacology: fast facts, A Norton professional book, New York, 2003; 320s.
    21. Strand J, Wise TN, Fagan PJ, Schmidt ChW jr. Erectile dysfunction and depression: category or dimension?, J. of Sex and Marital therapy, 2002; 28: 175-181. Go to original source... Go to PubMed...
    22. Wilson CA. Pharmacological targets for the control of male and female sexual behaviour. In: Riley AJ, Peet M, Wilson C, eds. Sexual Pharmacology, Oxford: Oxford Medical Publications, 1993; 1-58.
    23. Žourková A. Klinický význam CYP 2D6 v průběhu léčby novějšími antidepresivy. Čes. a Slov. Psychiat., 2002; 98: 273-277.
    24. Žourková A, Robeš M, Havlíková P, Obrovská V. Výskyt sexuálních dysfunkcí při léčbě antidepresivy u ambulantních pacientů Psychiatrické kliniky FN v Brně, Česká a Slovenská Psychiatrie, 2004; 100: 125-133.
    25. Žourková A. Dotazníky a škály měření sexuálních funkcí, Čes. a Slov. Psychiat., 2004; 100: 413-417.

    Return to the content


    Psychiatry for Practice

    Madam, Sir,
    please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
    Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

    I declare:

    1. that I have met the above instruction
    2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited

    No
    Yes

    If your statement is not true, please be aware
    that brings the risk of danger to their health or the health of others.